AU4712993A - New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods - Google Patents
New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methodsInfo
- Publication number
- AU4712993A AU4712993A AU47129/93A AU4712993A AU4712993A AU 4712993 A AU4712993 A AU 4712993A AU 47129/93 A AU47129/93 A AU 47129/93A AU 4712993 A AU4712993 A AU 4712993A AU 4712993 A AU4712993 A AU 4712993A
- Authority
- AU
- Australia
- Prior art keywords
- antibodies
- peptide
- peptides
- medicaments
- blocking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 7
- 239000003814 drug Substances 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 230000000903 blocking effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000178 monomer Substances 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 230000001363 autoimmune Effects 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000028996 humoral immune response Effects 0.000 abstract 1
- 102000035118 modified proteins Human genes 0.000 abstract 1
- 108091005573 modified proteins Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000036647 reaction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/7056—Lectin superfamily, e.g. CD23, CD72
- C07K14/70564—Selectins, e.g. CD62
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4216—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
- C07K16/4225—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Monomer peptide recognized by a humoral or cellular immune response introducing an auto-immune reaction in subjects infected by HIV-1 or 2, characterized in that it is selected in the group comprised particularly of SLWDQ, SLWDQSLK and DIISLWDQSLK, and in that it has, if desired, on the N terminal and C terminal side, from 1 to 5 other amino acids in a peptidic chain, and its multimers in linear sequence comprising from 2 to 6 monomer units, peptide, modified protein or protein fragment containing said peptide, peptide adjacent to said peptide, antibody, antiidiotypic antibody, medicament containing them and methods for treating AIDS.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9209884 | 1992-08-10 | ||
FR9209884A FR2694560B1 (en) | 1992-08-10 | 1992-08-10 | NOVEL VIRAL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, METHOD OF PREPARATION, APPLICATION AS MEDICAMENTS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM. |
FR9301628A FR2694938B1 (en) | 1992-08-10 | 1993-02-12 | NOVEL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, ANTI-IDIOTYPIC ANTIBODIES, APPLICATION AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM. |
FR9301628 | 1993-02-12 | ||
PCT/FR1993/000803 WO1994003487A1 (en) | 1992-08-10 | 1993-08-10 | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4712993A true AU4712993A (en) | 1994-03-03 |
Family
ID=26229655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU47129/93A Abandoned AU4712993A (en) | 1992-08-10 | 1993-08-10 | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0656010B8 (en) |
AT (1) | ATE202114T1 (en) |
AU (1) | AU4712993A (en) |
DE (1) | DE69330348D1 (en) |
FR (1) | FR2694938B1 (en) |
WO (1) | WO1994003487A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2290293A (en) * | 1994-06-08 | 1995-12-20 | Rupert Donald Holms | Preparation which inhibits the autoimmune response in HIV, or SLE, patients |
US5968753A (en) * | 1994-06-14 | 1999-10-19 | Nexell Therapeutics, Inc. | Positive and positive/negative cell selection mediated by peptide release |
US7514090B2 (en) * | 1998-06-29 | 2009-04-07 | The Center For Blood Research | Monocyte locomotion inhibitory factor |
KR100387169B1 (en) * | 2001-01-18 | 2003-06-12 | 노국진 | machine tool cutting oil a filter |
GB0228939D0 (en) * | 2002-12-12 | 2003-01-15 | Univ Nottingham | Peptide presentations for human immunodeficiency disease vaccines |
CA2528727A1 (en) * | 2003-06-10 | 2004-12-16 | The University Of Melbourne | Immunomodulating compositions, uses therefor and processes for their production |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0330359A3 (en) * | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition useful in the diagnosis and treating of hiv-1 infection |
PT90657B (en) * | 1988-05-27 | 1995-03-01 | Ortho Pharma Corp | PROCESS FOR THE PREPARATION OF PEPTIDES BLOCKING HIV-1 LIGATION CD4 RECEPTOR PROTEIN |
US4943628A (en) * | 1988-06-13 | 1990-07-24 | Ortho Pharmaceutical Corporation | HIV peptide-inducted T cell stimulation |
WO1990000566A1 (en) * | 1988-07-11 | 1990-01-25 | The Regents Of The University Of California | Inhibition of hiv-1 infection with soluble cd4 |
AU640619B2 (en) * | 1988-10-03 | 1993-09-02 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
-
1993
- 1993-02-12 FR FR9301628A patent/FR2694938B1/en not_active Expired - Fee Related
- 1993-08-10 AU AU47129/93A patent/AU4712993A/en not_active Abandoned
- 1993-08-10 AT AT93917862T patent/ATE202114T1/en not_active IP Right Cessation
- 1993-08-10 WO PCT/FR1993/000803 patent/WO1994003487A1/en active IP Right Grant
- 1993-08-10 DE DE69330348T patent/DE69330348D1/en not_active Expired - Lifetime
- 1993-08-10 EP EP93917862A patent/EP0656010B8/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
FR2694938B1 (en) | 1996-11-15 |
EP0656010B8 (en) | 2001-11-14 |
WO1994003487A1 (en) | 1994-02-17 |
EP0656010B1 (en) | 2001-06-13 |
FR2694938A1 (en) | 1994-02-25 |
DE69330348D1 (en) | 2001-07-19 |
EP0656010A1 (en) | 1995-06-07 |
ATE202114T1 (en) | 2001-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7197096A (en) | Peptides of human papilloma virus for use in human T cell response inducing compositions | |
CA2142007A1 (en) | Immunomodulatory peptides | |
ATE92502T1 (en) | ENVELOPE ANTIGENS OF HUMAN IMMUNODEFICIENCY VIRUS AND THEIR USES. | |
KR960704923A (en) | Peptides Capable of Inducing Immune Response to HIV and Anti-AIDS Agent for Preventing and Curing AIDS | |
HK1017261A1 (en) | Hybrid with interferon-alpha and an immunoglobulinfc linked through a non-immunogenic peptide. | |
NO891711L (en) | HIV ENV-CODED PEPTIDE AFFECTED FOR AA INJECTION ANTI-INHIBITIVE ANTIBODIES IN MAMMALS. | |
DE69326064D1 (en) | Human protein P53 peptides for use in human cytotoxic T cell response inducing compositions and human P53 protein specific T lymphocytes | |
IL93397A (en) | Pancreatic islet cell antigen protein or peptides, their preparation by molecular cloning, their use in the diagnosis of insulin dependent diabetes mellitus and pharmaceutical compositions comprising said antigens | |
DE68927379D1 (en) | SLIDE BLOCKING PEPTIDES | |
ZA936970B (en) | Anti-feline immunodeficiency virus (FIV) vaccines | |
ATE134195T1 (en) | PEPTIDE FRAGMENTS OF HIV | |
WO1993019178A3 (en) | Peptides useful for inducing tolerance | |
ZA943920B (en) | Pharmaceutical compositions | |
AU4712993A (en) | New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods | |
EP1878797A3 (en) | Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same | |
IT1249684B (en) | HEPATITIS VIRUS PROTEIN ENV EPITOPES | |
CA2128407A1 (en) | Synthetic peptides for a rubella vaccine | |
AU8976691A (en) | Selected peptides of the group-specific antigen (gag) of human immunodeficiency virus (hiv), the preparation and use thereof | |
DK0426314T3 (en) | HIV-related peptides | |
TW369600B (en) | Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same | |
KR950032286A (en) | Peptides with Human Immune Control Against Hepatitis B Virus | |
CA2143187A1 (en) | Anti-feline immunodeficiency virus (fiv) vaccines |